Stock Market News

Biogen's results beat estimates on strength in rare disease drugs

May 1, 2025 - 13:39
 0
Biogen's results beat estimates on strength in rare disease drugs
Read More

Tags:

Previous Article

Citi upgrades Derwent London to "buy," sees 48% upside on rental strength

Next Article

US weekly Initial Jobless Claims rise to 241K vs. 224K expected

Related Posts

State treasurers raise concerns over Musk's lack of focus on Tesla

State treasurers raise concerns over Musk's lack of foc...

Apr 22, 2025  0

US asset seizure not a credible threat, 'one of many risks' to monitor, Norway wealth fund says

US asset seizure not a credible threat, 'one of many ri...

Apr 24, 2025  0

Boeing outlook remains negative as S&P cites recovery risks

Boeing outlook remains negative as S&P cites recovery r...

Apr 28, 2025  0